Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Divalproex Sodium NDC 64725-0798 by Tya Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - 64725 0797

Label Image - 64725 0797

This is a description of a medication called Divalproex Sodium DR, which comes in tablet form with a potency of 250mg. The package contains 15 tablets and is coded with an NDC (National Drug Code) of 62756-797-88. The lot number is not provided, but it indicates that it was produced by Sun Pharma and repackaged by TY.A. Pharmaceuticals, located in Tallahassee, FL. The package insert should be consulted for dosing information as it is not provided.*

Label Image - 64725 0798

Label Image - 64725 0798

This is a description of a prescription drug called Divalproex Sod. DR 500MG TAB, which is available in a 100-count bottle. This drug can only be obtained with a prescription (RX ONLY) and the label contains the National Drug Code (NDC) 62756-798-88. The lot number is 00K and the expiration date is not specified (XX-XX-XX). It is manufactured by Sun Pharma and the packaging was handled by T.Y.A. Pharmaceuticals located in Tallahassee, FL. The label instructs to consult the package insert for dosage information.*

divalproex-na-fig1 - divalproex na fig1

divalproex-na-fig1 - divalproex na fig1

This text provides information about two studies where the efficacy of Divalproex sodium delayed-release tablets and Placebo was studied. The identification of the studies as "Study 1" and "Study 2" is given. The asterisk signifies statistical significance at a p-value of less than 0.05 for two different rating scales, YMRS and MRS.*

divalproex-na-fig2 - divalproex na fig2

divalproex-na-fig2 - divalproex na fig2

This text provides information on two studies involving the medication Divalproex Sodium Delayed-release Tablets, also known as DVPX. The first study involved a mean dose of 1087 mg/day, while the second study involved either a dose of 500 or 1000 mg/day. This information can be useful for medical professionals and researchers studying the use and effectiveness of Divalproex Sodium Delayed-release Tablets.*

divalproex-na-fig3 - divalproex na fig3

divalproex-na-fig3 - divalproex na fig3

divalproex-na-fig4 - divalproex na fig4

divalproex-na-fig4 - divalproex na fig4

divalproex-na-structure - divalproex na structure

divalproex-na-structure - divalproex na structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.